Key factors affecting the retention of production pharmacists in pharmaceutical manufacturing in South Africa
- Authors: Mvunyiswa, Mzwandile
- Date: 2022-04
- Subjects: Pharmaceutical industry , Pharmacists -- South Africa
- Language: English
- Type: Master's theses , text
- Identifier: http://hdl.handle.net/10948/58013 , vital:58498
- Description: he goal of the study was to look at elements that influenced the retention of production pharmacists in the pharmaceutical manufacturing industry. The South African pharmaceutical manufacturing industry is in charge of producing a wide range of pharmaceutical products for both the domestic and foreign markets. Production pharmacists are leaving the industry to pursue employment outside of the production environment, which is a problem for the industry. The goal of the study was to discover crucial factors that would help pharmacists in South Africa stay in the pharmaceutical product manufacturing industry. After doing a literature review to identify the determinants of retention, a hypothesis model was created to see if the identified factors had a positive link with pharmacist retention. The information was gathered via a survey with a questionnaire that was prepared and distributed to 81 people. Factor analysis confirmed the factors measured in the study, with Employee Reward and Recognition emerging as two separate factors. The study revealed that the factor of Employee Reward and Recognition (Factor A), which means receiving rewards and recognition was done in a fair and competitive manner did not relate to Employee Reward and Recognition as an actual Retention Factor (Factor B), or with Leadership, Training, Employee Career Development, Work-Life Balance or Job Security. In general, positive responses were received for Employee Reward and Recognition A (receiving rewards and recognition, and this was done in a fair and competitive manner), and neutral responses were received for Leadership, Work-Life Balance and Job Security and negative responses were recorded for Employee Career Development, Training and Employee Rewards and Recognition B (effectiveness of reward system to retain pharmaceutical talent). Pharmaceutical manufacturing companies must devise strategies to address the factors that elicited negative and neutral responses from the respondents. If the factors are not addressed, important talent, such as pharmacists, may be lost. , Thesis (MA) -- Faculty of Science, School of Environmental Sciences, 2022
- Full Text:
- Date Issued: 2022-04
Impact of a manufacturing execution system on production lead-times at a pharmaceutical company
- Authors: Kemp, Lizet
- Date: 2021-04
- Subjects: Pharmaceutical industry , Computer integrated manufacturing systems
- Language: English
- Type: Master's theses , text
- Identifier: http://hdl.handle.net/10948/51253 , vital:43238
- Description: Despite the development in computerised systems and in planning and manufacturing programmes since 1950, Pharma-X* still record their manufacturing processes manually, using a paper batch record, (Manufacturing Batch Records (MBR) or Batch Manufacturing Records (MBR)) and equipment logbooks. There can be up to five logbooks and an equipment control label for each type of equipment used at each process step, which must be completed manually before manufacturing can commence. This paper-based system is a laborious practice, as excessive time is spent completing manual entries into the MBRs and logbooks. Lean thinking, a popular manufacturing improvement philosophy, would describe any such activity as non-value adding and therefore waste (Melton, 2005). Pharma-X started implementing a manufacturing execution system (MES) in June 2018 to automate the manual entries of the manufacturing process. Once the MES is completely implemented, it will allow pharmacists the opportunity to review the manufacturing batch in real-time and to conduct investigations when an error occurs. MES will also allow the operators to complete logbooks with a single scan of equipment, as well as decrease manual entries into the MBR. This study was a quantitative research study comparing data of the past state (Pharma-X pre-MES) with data of a current state (Pharma-X post-MES implementation) to assess the impact of the implementation of a manufacturing execution system and lean manufacturing on a pharmaceutical company. A meaningful reduction in manufacturing lead time and reduction in time wastage were proven but further study and data documentation are recommended. , Thesis (M Pharm) -- Faculty of Health Sciences, 2021
- Full Text:
- Date Issued: 2021-04